|
|
News Breaks | | | | February 12, 2013 | | 07:35 EDT |  | STEM | StemCells announces first patient cohort completes spinal cord injury trial
StemCells announced that the twelve-month data from the first patient cohort in the company's Phase I/II clinical trial of its proprietary HuCNS-SC product candidate, or purified human neural stem cells, for chronic spinal cord injury continued to demonstrate a favorable safety profile, and showed that the considerable gains in sensory function observed in two of the three patients at the six-month assessment have persisted. The third patient remains stable. | |
|
News For STEM From The Last 14 Days Check below for free stories on STEM the last two weeks. |
|
|
| May 9, 2013 | | 16:28 EDT |  | STEM | StemCells reports Q1 EPS (17c), consensus (13c)
Reports Q1 revenue $284,000, consensus $290,000. | |
|
|
|
|
|
|
